Skip to content

Sprint Quattro Secure S® 6947M62Recalls & reported problems

Medtronic, Inc. · LEAD 6947M62 SPRINT US DF4 MCRD NG ACI · Class 3 · Implant

All models of Medtronic Sprint Quattro Lead (67) · Sprint Quattro Secure S (19)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
1
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169550957), received between Nov 7, 2018 and Sep 6, 2024 — classified as 1 death, 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Over-Sensing” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Over-Sensing2
  • Adverse Event Without Identified Device or Use Problem1
  • Impedance Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Cardiomyopathy1
  • Congestive Heart Failure1
  • Renal Failure1
  • Sepsis1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjurySep 6, 2024Over-Sensing; Impedance Problem; Over-Sensing; Impedance Problem

    IT WAS FURTHER REPORTED THAT THE LEAD WAS REPROGRAMMED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20157526 ↗
  • MalfunctionJun 26, 2024Over-Sensing; Over-Sensing

    IT WAS REPORTED THAT THE RIGHT VENTRICULAR (RV) LEAD TRIGGERED A LEAD INTEGRITY ALERT (LIA) DUE TO SENSING INTEGRITY COUNTER (SIC) AND HIGH-RATE NON-SUSTAINED EPISODES. ANOTHER LIA WAS TRIGGERED NINETEEN DAYS LATER DUE TO SIC AND HIGH-RATE NON-SUSTAINED EPISODES. ADDITIONALLY, IT WAS NOTED THAT THERE WAS VARIABLE R-WAVE MEASUREMENTS AND RV LEAD OVERSENSING THAT WAS NOTED ON STORED ELECTROGRAMS (EGM). THE RV LEAD REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19621116 ↗
  • DeathNov 7, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THE PATIENT IS DECEASED. THE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM WAS RETURNED WITH INFORMATION INDICATING THE PATIENT IS DECEASED AND THE CAUSE OF DEATH AS CONGESTIVE HEART FAILURE, CARDIOMYOPATHY, RENAL FAILURE AND SEPSIS. ADDITIONAL INFORMATION RELATED TO THE SOURCE OF THE SEPSIS WAS REQUESTED AND NOT RECEIVED.

    Patient problems: Cardiomyopathy; Congestive Heart Failure; Renal Failure; Sepsis

    MAUDE report 8045914 ↗

Other permanent pacemaker Electrode devices

All permanent pacemaker Electrode devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page